About diagnosis and therapy of bipolar disorder

Barkhatova A.N.

doi:https://doi.org/10.17116/jnevro2021121031155

Close metadata

Recommended articles:

Cognitive impairment in patients with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73

Current aspects of the relationship between depression and cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):66-74

Aripiprazole in the treatment of psychiatric disorders in childhood. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10-2):38-47

Search for risk factors for slowed intra-atrial conduction in patients with schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):111-116

Efficacy and safety of AVIANDR in the treatment of panic disorder: results of the first stage of the multicenter, randomized, placebo-controlled study. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):161-171

Characteristics, treatment features and in-hospital mortality of patients with myocardial infarction over 75 years old in Russia according to the REGION-IM registry. Russian Cardiology Bulletin. 2025;(1):22-38

Chronic obstructive pulmonary disease (COPD 2024). Clinical guidelines (short version). Journal of Respiratory Medicine. 2025;(2):5-16

Comparative analysis of microtextured breast implant shells. Plastic Surgery and Aesthetic Medicine. 2025;(2-2):13-15

Community-acquired pneumonia in adults. Clinical guidelines 2024 (short version). Journal of Respiratory Medicine. 2025;(3):6-18

Abstract:

The author describes diagnostic criteria and clinical symptoms of bipolar affective disorder (BAD) and summarizes the results of clinical studies on using modern antipsychotics to optimize BAD treatment. Preliminary recommendations for the use of aripiprazole in treatment of BAD, including exacerbation therapy and long-term maintenance therapy to prevent relapses, are presented.

Keywords:

bipolar disorder

therapy

augmentation

atypical antipsychotics

aripiprazole

Authors:

Barkhatova A.N.

Mental Health Research Center

Received:

27.01.2021

Accepted:

02.02.2021

Close metadata

References:

Mosolov SN, Kostyukova EG, Kuzavkova MV. Bipolyarnoe affektivnoe rasstrojstvo: diagnostika i terapiya. Pod red. Mosolova S.N. M.: MEDpress-inform; 2008. (In Russ.).
Kupfer DJ. Increasing medical burden in bipolar disorder. JAMA. 2005;293(20):2528-2530. https://doi.org/10.1001/jama.293.20.2528
McDonald KC, Bulloch AGM, Duffy A, Bresee L, Williams J, Lavorato D. Patten Prevalence of bipolar I and II disorder in Canada. Can J Psychiatry. 2015;60:151-156. https://doi.org/10.1177/070674371506000310
Bauer M, Glenn T, Alda M, Andreassen O, Angelopoulos E, Ardau R, Baethge C, Bauer R, Bellivier F, Belmaker RH, Berk M, Bjella TD, Bossini, Bersudsky Y, Cheung E, Conell J, Del Zompo M, Dodd S, Etain B, Fagiolini A, Frye M, Fountoulakis K, Garneau-Fournier J, Gonzalez-Pinto A, Harima H, Hassel, Henry C, Iacovides A, Isometsä E, Kapczinski F, Kliwick S, König B, Krogh R, Kunz M, Lafer B, Larsen, Lewitzka U, Lopez-Jaramillo C, MacQueen G, Manchia M, Marsh W, Martinez-Cengotitabengoa M, Melle I, Monteith S, Morken G, Munoz R, Nery FG, O’Donovan C, Osher Y, Pfennig A, Quiroz, Ramesar R, Rasgon N, Reif A, Ritter P, Rybakowski JK, Sagduyu K, Scippa AM, Severus E, Simhandl C, Stein DJ, Strejilevich S, Hatim Sulaiman A, Suominen K, Tagata H, Tatebayashi Y, Torrent C, Vieta E, Viswanath B, Wanchoo MJ, Zetin M, Whybrow PC. Influence of birth cohort on age of onset cluster analysis in bipolar I disorder. Eur Psychiatry. 2015;30:99-105. https://doi.org/10.1016/j.eurpsy.2014.10.005
Hwu HG, Yeh EK, Chang LY. Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatr Scand. 1989;79:136-147. https://doi.org/10.1111/j.1600-0447.1989.tb08581.x
Wittchen HU, Essau CA, von Zerssen D, Krieg JC, Zaudig M. Lifetime and sixmonth prevalence of mental disorders in the Munich Follow-Up Study. Eur Arch Psychiatry Clin Neurosci. 1992;241:247-258. https://doi.org/10.1007/BF02190261
Hirschfeld RMA, Holzer C, Calabrese JR, Weissman M, Reed M, Davies M, Frye MA, Keck P, McElroy S, Lewis L, Tierce J, Wagner KD, Hazard E: Validity of the Mood Disordr Questionnaire: A general population study. Am J Psychiatry. 2003;160:178-180. https://doi.org/10.1176/appi.ajp.160.1.178
Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DMS-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:18-19. https://doi.org/10.1001/archpsyc.1994.03950010008002
Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rössler W. Diagnostic issues in bipolar disorder. Europ Neuropsychopharm. 2003;13:43-50. https://doi.org/10.1016/S0924-977X(03)00077-4
Mosolov SN, Kostyukova EG, Kuzavkova MV. Profilakticheskoe primenenie antikonvul’santov pri faznoprotekayushchih endogennyh psihozah (sravnitel’noe izuchenie karbamazepina, val’proata natriya i solej litiya). V kn.: Antikonvul’santy v psihiatricheskoj i nevrologicheskoj praktike. Pod red. Vejn A.M., Mosolov S.N. Medicinskoe informacionnoe agentstvo; S-P; 1994;72-128. (In Russ.).
Mosolov SN, Kostyukova EG. Bipolyarnoe affektivnoe rasstrojstvo. Nacional’noe rukovodstvo. Psihiatriya pod rkd. Aleksandrovskij Yu.A., Neznanov N.G. Geotar Media; 2018;704-799. (In Russ.).
World Health Organization. The World Health Report 2001; Mental Health: New Understanding, New Hope. Geneva, WHO, 2001.
Joyce K, Thompson A, Marwaha S. Is treatment for bipolar disorder more effective earlier in illness course? A comprehensive literature review [Elektronnyi resurs]. International Journal of Bipolar Disorders. 2016;4(1). https://doi.org/10.1186/s40345-016-0060-6
Bauer MS, Kirk GF, Gavin C, Williford WO. Determinants of functional outcome and healthcare costs in bipolar disorder: a high intensity follow-up study. J Affect Disord. 2001;65:231-241. https://doi.org/10.1016/s0165-0327(00)00247-0
Dong M, Li Lu, Ling Zhang, Qinge Zhang, Gabor S, Ungvari, Chee H Ng, Zhen Yuan, Yifan Xiang, Gang Wang, Yu-Tao Xiang. Prevalence of suicide attempts in bipolar disorder: a systematic review and meta-analysis of observational studies. Epidemiology and Psychiatric Sciences. 2019;1-9. https://doi.org/10.1017/S2045796019000593
Koukopoulos AG, Sani G, Manfredi I, Pacchiarotti P, Girardi. Acta Psychiatr Scand. 2007;433:50-57. https://doi.org/10.1111/j.1600-0447.2007.00963.x
Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, Ayal Schaffer, David J Bond, Benicio N Frey, Verinder Sharma, Benjamin I Goldstein, Soham Rej, Serge Beaulieu, Martin Alda, Glenda MacQueen, Roumen V Milev, Arun Ravindran, Claire O’Donovan, Diane McIntosh, Raymond W Lam, Gustavo Vazquez, Flavio Kapczinski, Roger S McIntyre, Jan Kozicky, Shigenobu Kanba, Beny Lafer, Trisha Suppes, Joseph R Calabrese, Eduard Vieta, Gin Malhi, Robert M Post and Michael Berk, «Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders» (ISBD), 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97-170. https://doi.org/10.1111/bdi.12609
Swann AC, Lafer B, Perugi G, et al. Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. American Journal of Psychiatry. 2013;170(1):31-42. https://doi.org/10.1176/appi.ajp.2012.12030301
Calabrese JR, Hirschfeld RM, Frye MA, Reed ML. Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample. Journal of Clinical Psychiatry. 2004;65:1499-1504. https://doi.org/10.4088/jcp.v65n1109
Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Health Technol Assess. 2004;8(19):iii-iv:1-187. PMID: 15147609. https://doi.org/10.3310/hta8190
Keck PE Jr, Calabrese JR, McIntyre RS, McQuade R, Carson W, Eudicone J, Carlson B, Marcus R, Sanchez R. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100week, doubleblind study versus placebo. J Clin Psychiatry. 2007;68(10):14801491. https://doi.org/10.4088/jcp.v68n1003
Thase ME, Jonas A, Khan A, Bowden C, Wu X, McQuade R, Carson W, Marcus R, Owen R. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebocontrolled studies. J Clin Psychopharmacol. 2008;28(1):1320. https://doi.org/10.1097/jcp.0b013e3181618eb4
Derry S, Moore RA. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials. BMC Psychiatry. 2007;740. https://doi.org/10.1186/1471-244X-7-40
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Muller HJ, Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania. World J Biol Psychiatry. 2009;10:85116. https://doi.org/10.1080/15622970902823202
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Muller HJ, Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP] Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14:154-219. https://doi.org/10.3109/15622975.2013.770551
Ogawa Y, Tajika A, Takeshima N, Hayasaka Y, Furukawa TA. Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy. CNS Drugs. 2014;28. https://doi.org/10.1007/s40263-014-0197-8
Bellantuono C., Di Massimo G., Mauro A., Martellini M., Nardi B. Aripiprazole in pregnancy: a review of literature. Riv Psichiatr. Jan-Feb 2015;50(1):8-11. PMID: 25805349 https://doi.org/10.1708/1794.19526.